Sale!

Colon Cancer Comprehensive Panel NGS Genetic DNA Test

Original price was: $750.Current price is: $500.

-33%

The Colon Cancer Comprehensive Panel NGS Genetic DNA Test is a cutting-edge genetic screening tool that analyzes 34 key genes associated with hereditary colon cancer risk. Using next-generation sequencing technology, this comprehensive test identifies mutations in genes like APC, BRCA1, BRCA2, MLH1, MSH2, and others that significantly increase colon cancer susceptibility. For just $500 USD, patients receive detailed insights into their genetic predisposition, enabling early intervention and personalized prevention strategies. This test is particularly valuable for individuals with family history of colon cancer, allowing for proactive healthcare decisions and improved cancer surveillance.

Clinically Validated & Lab Certified

  • ISO-Accredited Laboratory, Ensuring Highest Standards
  • Trusted by Hospitals & Patients —Accredited Testing with Results
  • Direct Healthcare Provider Support + Comprehensive Reporting
Guaranteed Safe Checkout

Colon Cancer Comprehensive Panel NGS Genetic DNA Test

Comprehensive Genetic Screening for Hereditary Colon Cancer Risk

The Colon Cancer Comprehensive Panel NGS Genetic DNA Test represents a breakthrough in preventive oncology, offering individuals unprecedented insight into their genetic predisposition for colon cancer. This advanced diagnostic tool utilizes next-generation sequencing (NGS) technology to analyze 34 critical genes associated with hereditary colon cancer syndromes, providing a comprehensive assessment of inherited cancer risk factors that can guide personalized prevention and early detection strategies.

What This Revolutionary Test Measures

Our comprehensive genetic panel examines mutations across multiple gene families that significantly impact colon cancer development:

  • DNA Mismatch Repair Genes: MLH1, MSH2, MSH6, PMS2, EPCAM
  • Tumor Suppressor Genes: APC, TP53, PTEN, STK11
  • DNA Damage Response Genes: BRCA1, BRCA2, ATM, CHEK2, PALB2
  • Polymerase Proofreading Genes: POLD1, POLE
  • Additional High-Risk Genes: AXIN2, BLM, BMPR1A, CDH1, CDKN2A, FLCN, GALNT12, MLH3, MSH3, MUTYH, NBN, NTHL1, PRSS1, RNF43, SMAD4, TGFBR2, VHL

Who Should Consider Genetic Testing

This comprehensive panel is particularly recommended for individuals with:

  • Personal history of colon cancer diagnosed before age 50
  • Multiple family members with colon cancer across generations
  • Family history of Lynch syndrome or familial adenomatous polyposis (FAP)
  • Personal or family history of multiple cancer types (endometrial, ovarian, gastric)
  • Ashkenazi Jewish ancestry with family cancer history
  • Unexplained gastrointestinal symptoms with family cancer patterns
  • Previous abnormal colonoscopy findings or numerous polyps

Transformative Benefits of Genetic Insight

Understanding your genetic risk profile provides numerous advantages:

  • Early Intervention Opportunities: Identify high-risk individuals before cancer develops
  • Personalized Screening Protocols: Tailor colonoscopy frequency based on genetic risk
  • Family Risk Assessment: Inform relatives about potential inherited risks
  • Preventive Strategies: Implement lifestyle modifications and chemoprevention when appropriate
  • Peace of Mind: Reduce uncertainty through definitive genetic information
  • Comprehensive Risk Evaluation: Assess associated cancer risks beyond colon cancer

Understanding Your Genetic Test Results

Your comprehensive genetic report will provide clear guidance:

  • Positive Result: Indicates a pathogenic mutation was identified, requiring consultation with a genetic counselor and oncologist to develop personalized management plans
  • Negative Result: No known pathogenic mutations detected, though continued routine screening may still be recommended based on family history
  • Variant of Uncertain Significance (VUS): A genetic change with unclear cancer risk implications, requiring periodic re-evaluation as research advances
  • Professional Interpretation: All results include detailed explanations and recommendations from our board-certified genetic specialists

Test Pricing and Availability

Test Name Discount Price Regular Price
Colon Cancer Comprehensive Panel NGS Genetic DNA Test $500 USD $750 USD

Nationwide Accessibility

GGC DNA maintains comprehensive testing facilities across major metropolitan areas throughout the United States, including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, Austin, Jacksonville, Fort Worth, Columbus, Charlotte, San Francisco, Indianapolis, Seattle, Denver, Washington DC, Boston, El Paso, Nashville, Detroit, Oklahoma City, Portland, Las Vegas, Memphis, Louisville, Baltimore, and Milwaukee. Our extensive network ensures convenient access to cutting-edge genetic testing regardless of your location.

Take Control of Your Genetic Health Today

Don’t leave your cancer risk to chance. Our Colon Cancer Comprehensive Panel provides the definitive genetic information needed to make informed healthcare decisions. With results typically available within 3-4 weeks and multiple sample collection options including blood, extracted DNA, or simple FTA card blood spots, getting tested has never been more convenient.

Ready to uncover your genetic risk profile? Contact our genetic specialists today at +1(267) 388-9828 or schedule your comprehensive assessment through our online booking system. Take the first step toward personalized cancer prevention and early detection strategies tailored to your unique genetic makeup.